AML or MDS Undergoing Reduced-Intensity Transplant · Phase 1 · NCT06996119
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
City of Hope Medical Center · Open the brief
Sezary Syndrome · Фаза 2 · NCT04256018
Mogamulizumab, LD TSEBT
Stanford University · Open the brief
Large B-cell Lymphoma · Фаза 2 · NCT07316010
Leukapheresis, Lymphodepleting Chemotherapy
M.D. Anderson Cancer Center · Open the brief
Recurrent Follicular Lymphoma · Фаза 2 · NCT04587687
Bendamustine Hydrochloride, Brentuximab Vedotin
University of California, Davis · Open the brief
Multiple Myeloma · Фаза 2 · NCT06107738
Iberdomide, Daratumumab/rHuPH20 Co-formulation
Barbara Ann Karmanos Cancer Institute · Open the brief
Acute Myeloid Leukemia, Relapsed, Adult · Фаза 2 · NCT06802315
Intensity modulated total marrow irradiation, Cyclophosphamide (CTX), Fludarabine (Fludara), Busulfan (conditioning for ALLO Transplant)
University of Illinois Chicago · Open the brief
Acute Myeloid Leukemia · Фаза 2 · NCT05401097
Azacitidine, Biopsy, Enasidenib, Ivosidenib
Alice Mims · Open the brief
High-Risk Acute Leukemia or Myelodysplastic Syndrome · Phase 1/2 · NCT03670966
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Fred Hutchinson Cancer Center · Open the brief
Acute Lymphoblastic Leukemia · Phase 1/2 · NCT03128034 · Papers
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Fred Hutchinson Cancer Center · Open the brief
Aplastic Anemia · Фаза 2 · NCT01624805
Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, Methylprednisolone
M.D. Anderson Cancer Center · Open the brief
Acute Myeloid Leukemia · Phase 1 · NCT04024761 · Papers
CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Dana-Farber Cancer Institute · Open the brief
Acute Myeloid Leukemia · Phase 1 · NCT06138587
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
Dana-Farber Cancer Institute · Open the brief
Acute Myeloid Leukemia · Phase 1 · NCT03113643 · Papers
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Dana-Farber Cancer Institute · Open the brief
Multiple Myeloma · Phase 1 · NCT04483206 · Papers
Personalized Autologous Transplant for Multiple Myeloma
Emory University · Open the brief
Chronic Lymphocytic Leukemia · Фаза 2 · NCT07271667
Emavusertib, Zanubrutinib
Curis, Inc. · Open the brief
Hairy Cell Leukemia · Фаза 2 · NCT00412594 · Papers
Cladribine, Laboratory Biomarker Analysis, Rituximab
M.D. Anderson Cancer Center · Open the brief
Untreated Nodal T Follicular Helper Cell Lymphoma · Phase 1 · NCT07278856
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
City of Hope Medical Center · Open the brief
Multiple Myeloma · Phase 1 · NCT07581704
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
Christopher Strouse · Open the brief
Central Nervous System Lymphoma · Phase 1 · NCT05625594
Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma
City of Hope Medical Center · Open the brief
Recurrent Acute Lymphoblastic Leukemia · Phase 1 · NCT05418088
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
Sumithira Vasu · Open the brief
AML/MDS · Phase 1 · NCT04318678 · Papers
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
St. Jude Children's Research Hospital · Open the brief
Acute Myeloid Leukemia and Other Myeloid Malignancies · Phase 1/2 · NCT06928662
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Fred Hutchinson Cancer Center · Open the brief
Secondary CNS Lymphoma · Phase 1 · NCT06730542
Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma
Juan P. Alderuccio, MD · Open the brief
Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma · Phase 1/2 · NCT07225985
Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center · Open the brief